-
psnet.ahrq.gov/node/43942/psn-pdf
March 11, 2015 - FDA requires label warnings to prohibit sharing of multi-
dose diabetes pen devices among patients.
March 11, 2015
FDA Safety Communication. Silver Spring, MD: US Food and Drug Administration; February 25, 2015.
https://psnet.ahrq.gov/issue/fda-requires-label-warnings-prohibit-sharing-multi-dose-diabetes-pen-device…
-
psnet.ahrq.gov/node/44771/psn-pdf
January 06, 2016 - Could it be done safely? Pharmacists views on safety and
clinical outcomes from the introduction of an advanced
role for technicians.
January 6, 2016
Napier P, Norris P, Braund R. Could it be done safely? Pharmacists views on safety and clinical outcomes
from the introduction of an advanced role for technicians. R…
-
psnet.ahrq.gov/node/43210/psn-pdf
May 28, 2014 - Improving cancer patient care with combined medication
error reviews and morbidity and mortality conferences.
May 28, 2014
Ranchon F, You B, Salles G, et al. Improving Cancer Patient Care with Combined Medication Error
Reviews and Morbidity and Mortality Conferences. Chemotherapy (Los Angel). 2014;59(5).
doi:10.11…
-
www.ahrq.gov/patient-safety/reports/national-action-plans.html
February 01, 2018 - National Action Plans
The work of AHRQ and other Federal agencies is guided by work groups, committees, investigators and expert advisors who contribute to reports on specific topics that impact health care.
National Action Plans
National Action Plans are developed with expert input to provide a framework f…
-
www.ahrq.gov/sites/default/files/wysiwyg/data/SyH-DR-Pharmacy-Level-claims-2024.pdf
January 01, 2024 - SyH-DR Data Dictionary: Pharmacy-Level Variables
SyH-DR Data Dictionary: Pharmacy-Level Variables
Variable Label Variable Name Medicare
File
Medicaid
File
Commercial
File
Variable
Type
Variable
Length
Synthesized,
Masked,
Suppressed
Note /
Rule**
Claim Number CLM_CNTL_NUM X NUM 8 Masked…
-
www.ahrq.gov/prevention/guidelines/tobacco/clinicians/presentations/2008update-full/slide127.html
October 01, 2014 - 127. Treatment Recommendations: Medications (Continued)
Treating Tobacco Use and Dependence: 2008 Update
Text version of slide presentation.
Clinical guidelines for prescribing medication for treating tobacco use and dependence (continued)
When should second-line agents be used for treating tobacc…
-
psnet.ahrq.gov/node/844987/psn-pdf
February 22, 2023 - Examining medication ordering errors using AHRQ
Network of Patient Safety Databases.
February 22, 2023
Grauer A, Rosen A, Applebaum JR, et al. Examining medication ordering errors using AHRQ network of
patient safety databases. J Am Med Inform Assoc. 2023;30(5):838-845. doi:10.1093/jamia/ocad007.
https://psnet.ahr…
-
www.uspreventiveservicestaskforce.org/uspstf/integrating-evidence-based-clinical-and-community-strategies-to-improve-health---table-1
November 01, 2013 - Integrating Evidence-Based Clinical and Community Strategies to Improve Health - Table 1
Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
The Leading and Actual Causes of Death, United States, 2000
Leading cause of …
-
www.ahrq.gov/sites/default/files/wysiwyg/data/infographics/qdr-infographic-opioids.pdf
January 01, 2013 - Dramatic Rise in Opioid-Related Deaths, Especially Among Blacks
Dramatic Rise in Opioid-Related Deaths,
Especially Among Blacks
Non-Hispanic Blacks
18-fold increase
in mortality
Non-Hispanic Whites
9-fold increase
in mortality
Hispanics
12-fold increase
in mortality
0.5 to 9
deaths
per 100,000
populat…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/rapid-reviews-end-user_white-paper.pdf
April 01, 2016 - the increasing
interest in rapid reviews and their methodologies, including the Canadian Agency for Drugs … The Evidence Inventory was produced by the Canadian Agency for Drugs and Technologies
in Health,
11 … literature and pertinent research issues;
Horizon Scanning aims to identify new, or new uses of existing, drugs … Canadian Agency for Drugs in Technologies in
Health.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-artery-disease-testing_research-protocol.pdf
January 15, 2015 - renal failure, allergy,
nephrogenic systemic fibrosis, contrast-related harms, adverse reactions to drugs … Technologies that are no longer
available or no longer widely
used (e.g., MUGA, planar
nuclear imaging)
• Drugs … without myocardial echo contrast)
A person’s heart is stressed either through exercise or the use of drugs … Pharmacologic stress magnetic resonance imaging (MRI)
Drugs are used to stress the heart and then an
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/registries-guide-2nd-edition_disposition-comments.pdf
March 03, 2010 - thereby
allowing legitimate comparisons, to the extent possible, across types and
generations of drugs … Source: www.effectivehealthcare.ahrq.gov
Published Online: March 3, 2010
Page 12, Orphan Drugs … interpretable long‐term safety data as they may allow
objective comparisons across generations of drugs
-
hcup-us.ahrq.gov/reports/SOI.jsp
June 01, 2016 - A Severity-of-Illness Classificiation for Mental and Substance-Use Disorders for Use With Hospital Administrative Data
An official website of the Department of Health & Human Services
Search All AHRQ We…
-
hcup-us.ahrq.gov/reports/ED_MHSA_SOIpaper.pdf
June 10, 2011 - A sample article title
MAINTAIN AND EXPAND
THE HEALTHCARE COST AND UTILIZATION PROJECT (HCUP)
Contract No. HHSA-290-2006-00009-C
A SEVERITY-OF-ILLNESS CLASSIFICATION FOR MENTAL AND
SUBSTANCE-USE DISORDERS FOR USE WITH HOSPITAL
ADMINISTRATIVE DATA
June 10, 2011
…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/fibromyalgia_research-protocol.pdf
April 03, 2014 - The extent to which adverse effects from
treatments, especially pharmaceuticals are more common, more … Antiepileptics (such as pregabalin or gabapentin)
o Non-opioid analgesics
o Nonsteroidal anti-inflammatory drugs … comorbidities, other
chronic pain
conditions or longer
duration of symptoms
Adverse effects
of drugs … We will also review Scientific Information Packets sent by manufacturers for relevant
pharmaceuticals
-
digital.ahrq.gov/sites/default/files/docs/publication/p20hs014908-bergner-final-report-2005.pdf
January 01, 2005 - El Dorado County Safety Net Technology Project
Grant Final Report
Grant ID: 1 P20 HS014908-01
El Dorado County Safety Net Technology Project
Inclusive dates: 09/30/04 - 09/29/05
Principal Investigator:
Dr. Greg Bergner
Team members:
Jon Lehrman
Sandra Dunn
Chris Weston
Mike Weiher
Pat …
-
hcup-us.ahrq.gov/db/nation/nis/NIS_Sources_and_Restrictions_2001.pdf
January 01, 2001 - Sources of NIS Data and State-Specific Restrictions
2001
AZ Arizona Department of Health Services
No restrictions
CA Office of Statewide Health Planning & Development
No restrictions
CO Colorado Health & Hospital Association
No restrictions
CT CHIME, Inc. …
-
www.ahrq.gov/research/findings/making-healthcare-safer/mhs3/exe-summary.html
March 01, 2020 - Making Healthcare Safer III: Executive Summary
ES. 1 Background/Introduction
The Making Health Care Safer reports from the Agency for Healthcare Research and Quality (AHRQ) have had an important role in reducing harm and improving the safety and quality of care for patients. The reports—providing an analysis …
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/eSLqaKpvzhYRbQVeumNgSQ
January 19, 2021 - None of the drugs were
associated with serious adverse events. … Evidence is still
needed to compare different forms, doses, and durations of
drugs; to compare drugs … more than the use of a single NRT product (RR, 1.25
[95% CI, 1.15-1.36])
Direct comparisons between drugs
-
digital.ahrq.gov/sites/default/files/FINAL%20OO%20PC%20CDS%20SDM%20Report.pdf
September 01, 2023 - understand the risk of drug interactions between
blood thinners and nonsteroidal anti-inflammatory drugs … Shared Decision-making Tool for Drug
Interactions Between Warfarin and
Nonsteroidal Anti-inflammatory Drugs